Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin

Gene Therapy

Volumn 10, Issue 12, 2003, Pages 1035-1040

  Ross, R ^a   Sudowe, S ^a   Beisner, J ^a   Ross, X L ^a   Ludwig Portugall, I ^a   Steitz, J ^a,b   Tuting T ^a,b   Knop, J ^a   Reske Kunz, A B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Dendritic cell; DNA vaccination; Fascin; Gene therapy; Langerhans cell

Indexed keywords

BETA GALACTOSIDASE; CD8 ANTIGEN; CYTOSKELETON PROTEIN; DNA VACCINE; FASCIN; GREEN FLUORESCENT PROTEIN; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL MATURATION; CELL SPECIFICITY; CELL TYPE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DENDRITIC CELL; EXPRESSION VECTOR; GENE EXPRESSION; GENE GUN; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SUPPRESSOR CELL; VACCINATION;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MURINAE; VECTORS;

EID: 0038008013     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301968     Document Type: Article

References (25)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
2. Tüting T, DeLeo AB, Lotze MT, Storkus WJ. Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or 'self' antigens induce antitumor immunity in vivo. Eur J Immunol 1997; 27: 2702-2707.
3. Timares L, Takashima A, Johnston SA. Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc Natl Acad Sci USA 1998; 95: 13147-13152.
4. Kündig TM et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 1995; 268: 1343-1347.
5. Nickoloff BJ, Turka LA. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 1994; 15: 464-469.
6. Gaspari AA, Katz SI. Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes. J Immunol 1991; 147: 4155-4161.
7. Ross R et al. The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells. J Immunol 1998; 160: 3776-3782.
8. Ross R et al. Mouse Langerhans cells differentially express an activated T cell-attracting CC chemokine. J Invest Dermatol 1999; 113: 991-998.
9. Ross R et al. Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation. J Invest Dermatol 2000; 115: 658-663.
10. Jaffe R, DeVaughn D, Langhoff E. Fascin and the differential diagnosis of childhood histiocytic lesions. Pediatr Dev Pathol 1998; 1: 216-221.
11. Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356: 152-154.
12. Condon C et al. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996; 2: 1122-1128.
13. Porgador A et al. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med 1998; 188: 1075-1082.
14. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158: 2723-2730.
15. Xu S et al. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J Immunol 1995; 154: 2697-2705.
16. Valladeau J et al. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 2002; 168: 782-792.
17. Gambotto A et al. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Therapy 2000; 7: 2036-2040.
18. Steitz J, Brück J, Knop J, Tüting T. Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism. Gene Therapy 2001; 8: 1255-1263.
19. Morita A et al. Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter. Gene Therapy 2001; 8: 1729-1737.
20. + T cell responses in gene gun DNA immunization. J Immunol 2001; 167: 5549-5557.
21. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997; 185: 541-550.
22. Jonuleit H et al. Induction of interleukin 10-producing, non-proliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213-1222.
23. Ochsenbein AF et al. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 2001; 411: 1058-1064.
24. Ross R et al. Nonradioactive detection of differentially expressed genes using complex RNA or DNA hybridization probes. Biotechniques 1999; 26: 150-155.
25. Sudowe S, Rademaekers A, Kölsch E. Antigen dose-dependent predominance of either direct or sequential switch in IgE antibody responses. Immunology 1997; 91: 464-472.